Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg
|
|
- Paul Neal
- 6 years ago
- Views:
Transcription
1 EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg 1. Opening of the full Think Tank meeting - DG SANCO. The main points of discussion to be addressed during the meeting were introduced. The importance of supporting and maintaining the CSF and the Think Tank meeting as good and efficient frameworks for discussing in an open and transparent way the HIV/AIDS situation in EU and in the neighbouring countries was underlined, especially taking into account the economical crisis EU is experiencing and its potential impacts on the health situation. Epidemiological and behavioural surveillance, investing in prevention, access to treatment were indicated as the key points of the EC Communication on HIV/AIDS to be continuously discussed and brought forward. 2. Civil Society Forum (CSF) report The CSF co-chair Mrs Cosmaro and Mrs Zakowicz reported on the main issues of discussion during the CSF. Among them: i) how Civil Society Organizations can act more efficiently in keeping HIV/AIDS in the agenda of EU Presidencies; ii) the access to treatment in times of financial crisis, especially in terms of the stock-out problems; iii) the specific issues of lowprevalence countries; iv) the human rights and the still ongoing problem with criminalization of people infected with HIV. The information on the Oslo Declaration on HIV criminalisation and the legislative changes around criminalisation in Switzerland were presented as positive achievements in this context. By contrast, the anti gay law in St Petersburg raised some questions and worries and will require a close follow-up. Promoting early HIV testing and timely care as well as the situation in Greece represented other important topics of discussion during the CSF. A detailed report of the CSF meeting will be published separately on the website of AIDS Action Europe. 3. Developments in Member States reports
2 The session was opened with a talk on "The HIV situation in Spain" given by the Spanish representative, and followed by Mr Casabona, of the Centre for Epidemiologic Studies of Sexually Transmitted Diseases and AIDS in Catalonia (CEEISCAT), presenting the results obtained so far in the context of the EC funded project COBATEST. This project is focused on how to improve HIV testing by increasing HIV community based testing practices in Europe. During the discussion the issue of a possible limitation in access to HIV treatment for irregular immigrants in Spain was raised. Mr. Nikolopoulos, representative of KEELPNO (the Greek Center for Disease Control and Prevention), opened the session by addressing the HIV situation in Greece, and by presenting the latest available data based on the national HIV/AIDS reporting system, second generation surveillance sources, and a molecular epidemiology study recently carried out. Overall, the data indicate an ongoing increase in HIV infections among injecting drug users (IDU), in particular in the central part of Athens. It was stated that, according to the HIV/AIDS reporting system, the percentage of migrants among the reported HIV-positives has remained stable. An avidity test conducted on 62 samples has clearly showed that these cases represent recent infections. Moreover, it has been possible to demonstrate the substantial networking of HIV infections in the population of drug injectors in The measures introduced by public authorities to tackle the situation were presented and in particular the increase in the number of distributed clean needles and syringes was highlighted. Mr. Dedes, representing the Greek Civil Society point of view, confirmed that migrants clearly do not represent the driving force of HIV spreading in Greece and warned against wrong political messages and misinterpretations. Mr. Dedes also reported on the detention and forced HIV testing of women accused of soliciting sex operated by the Greek authorities. Finally, the ECDC reported the first preliminary results and consequent recommendations resulting from a technical mission that ECDC carried on in Athens along with ECMDDA and WHO, upon specific request of the Commission. A representative of the CSF and of the Agency for Fundamental Rights also participated in the mission, the second one as an observer. Moreover, by the end of September October ECDC will deliver a full risk assessment on the situation. The UK representative presented UK initiatives on reaching key populations (especially MSsM) for testing (Reaching key populations for HIV testing) while Mrs Lulei, from BZgA, gave an overview on the German campaign for World AIDS day "Living together positively. Be safe" (Living together positively. Be safe! - The German campaign for World AIDS Day). During discussion the issue of how to measure the impact of awareness campaigns on HIV prevention was raised.
3 4. HIV in Eastern Europe what about the future During this session an overview of the HIV situation in Eastern Europe, comprising also Central Asia Countries, was given by ECDC and WHO Europe. One of remaining pressing issues is still the difficulty for key populations to reach testing and treatment. Mrs. Kurbatova, from the Estonian National Institute for Health Development, presented in detail the situation in Estonia. Here, IDUs represent the main target group (roughly 70% of all cases). IDU prevalence is mostly confined to two (out of 15) counties Harjumaa including Tallinn and Ida-Virumaa (North-East). Different co-morbidities in particular HIV/IDU, HIV/TB, TB/IDU, IDU/HIV/TB, IDU/HIV/MDR-TB represent an important issue to be further addressed. Estonia has a National HIV and AIDS prevention strategy running with 3 main objectives: harm reduction programs for people who inject drugs (syringe exchange programs, substitution treatment, counselling); HIV testing (based on risk behaviors and indicator conditions); HIV-related health care services including ARV treatment free of charge for all. In a study published last year (Uusküla A et al. "Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia" BMC Public Health Jun 30;11:517) it has been clearly shown that in Estonia a decrease in the HIV prevalence among new injectors and in the numbers of people initiating injection drug use coincided with implementation of large-scale syringe exchange programmes. Of course, further reduction in HIV transmission among IDUs is still required. Also the OSTs have been implemented from 2004 to 2011 and are now provided also in prisons and detention housings. Importantly, the Ministry of Interior has taken over coordination of the national drug policy. This should provide the necessary political commitment towards the implementation of different interventions still needed to tackle HIV among IDUs. The representative of the Russian Federation reported in detail the HIV situation in the RF, showing the constant increase in PLWH and in newly diagnosed cases of infection. The main achievements of the Russian Federation in the fight against HIV/AIDS are represented by 100% testing of donated blood; up to 100% of pregnant women tested for HIV; decrease of HIV transmission from mother to child from 30% to 8.5% in 2011; near of people (1/5,5 of living with HIV) covered by antiretroviral therapy. Mr. Shukov underlined that Russian Federation is investing on basic science, vaccine development, and research of new targets for therapy, drug development and strategies to increase local production of drugs to
4 cut down the prices. All these lines of actions are important also in the context of Russian Federation's cooperation with neighbouring Countries on HIV prevention. Both Estonia and Russian Federation reported difficulties related to medical and nursery personal leaving the Country due to economic reasons. 5. HIV/AIDS co-infections open issues During this session the ECMDDA presented data on the transmission of hepatitis among IDUs in Europe. In particular the high prevalence of HCV infection among IDUs represents a serious public health problem for the EU, made worse by the fact that many of those who have contracted the virus are unaware of their infection status was shown. The ECDC gave a short report on the ECDC TB action plan, illustrating the complexity of the TB situation in the EU. Testing and reporting on HIV serostatus of TB cases is still largely incomplete. Indeed, only a limited number of countries currently collect and report data on TB/HIV co-infection. This low coverage is likely related to different kind of barriers. Among them, one of the most important is the lack of collaboration between TB and HIV surveillance systems. Thus, the implementation of a European Reference Laboratory Network for TB should help to make progress. Mr. Lundgren, from University of Copenhagen, addressed the problem of HIV and coinfections focusing on open issues in prevention, treatment and care. In this context, cancer is an increasing problem for people living with HIV/AIDS, not only because of their immune status but also because of co-infection with oncogenic viruses, in particular HPV, HBV and HCV. The rational of employing HPV and HBV vaccination in HIV positive patients was discussed as well as new therapeutic options for HIV/HCV co-infected patients. Moreover, a TB co-infection is still one of the main issues for people living with HIV/AIDS, especially due to the fact that MDR TBs are spreading. Furthermore data show that co-infection with syphilis co-infections is a major problem, especially among MSM. 6. ECDC reports (i) Technical mission in Greece (see point 3) (ii) Overview on the epidemiological situation in Eastern Europe (see point 4) (iii) Short update on the TB plan (see point 5) (iv) Behavioural surveillance project. The overall goals of this projects are: the mapping of HIV/STI behavioural surveillance systems in the EU/EEA; the survey on 8 sub-populations including general population, youth, MSM, migrants, IDU, PLWHA, sex workers, STI clinic
5 attendees; the harmonisation of indicators and the outline of the methods for implementing behavioural surveillance. The ECDC presented the interim results and the on-going support for countries through regional workshops and addressed possible ways forward on this topic. 7. Health Programme and Research Framework Programme. While Mrs von Rueden, from Bundeszentrale für gesundheitliche Aufklärung (BZgA), presented the outline and the main goals of the Joint Action on QA/QI in HIV prevention, the Commission Directorate General for Research and Innovation, gave an overview on the EUfunded HIV/AIDS projects under the current 7th Framework programme (FP7) and on the future Research Programme Horizon HIV and co-infection prevention concepts for the future. Mrs Oosterhoff, from the Royal Tropical Institute (KIT), presented the main objectives of the project and the deliverables produced so far. This tender raised profound discussions on the delivery of data and information by Member States as well as on the realisation of the work as such. 9. Conferences The World AIDS conference that will take place in July in Washington, DC and a "HIV and human rights" conference was planned in November in Brussels (now postponed to May 2013). In particular, for the Conference on HIV and Human Rights both, selected Thank Tank and CSF members will be part of the coordinating committee that will elaborate the Conference agenda and main topics for discussion. More information on this topic will be provided in the next regular TT meeting.
ECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationAction Plan on HIV/AIDS in the EU and neighbouring countries:
Action Plan on HIV/AIDS in the EU and neighbouring countries: 2014-2016 Matthias Schuppe Policy Officer Health Threats Unit DG Health and Consumers European Commission Outline o EU policy framework on
More informationECDC s role in the fight against HIV/AIDS in Europe
European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November
More informationECDC update to the EU Commission Think Tank on HIV/AIDS
ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think
More informationMid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006
Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic
More informationHealth Programme support to the European Action Plan HIV/AIDS
Health Programme 2008-2013 support to the European Action Plan HIV/AIDS 2009-2012 Executive Agency for Health and Consumers EAHC Cinthia Menel Lemos Cinthia.menel-lemos@ec.europa.eu What are the news?
More informationANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)
ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationViral Hepatitis Burden and Policy Directions in the European Region of WHO
Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all
More informationGLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
More informationEMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS
EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS Cinthia Menel Lemos cinthia.menel-lemos@ec.europa.eu Project Officer Executive Agency for Health
More informationNDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Goals for the HIV/AIDS & AI Expert Group Goal 2: Prevention
More informationWorld Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationPrevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs
Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject
More informationCONCEPT NOTE. Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems
CONCEPT NOTE Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems Official event in the programme of the Estonian Presidency of the Council of the European Union Co-organised
More informationAs a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More informationThe new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
More informationTB/HIV in the WHO European Region Overview, Priorities & Response
TB/HIV in the WHO European Region Overview, Priorities & Response 16 th Core Group Meeting TB/HIV Working Group Stop TB Partnership Almaty, Kazakhstan May 2010 Martin Donoghoe Andrei Dadu, Smiljka de Lussigny
More informationAs a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
More informationFigure 1: Newly diagnosed HIV-cases and total number of HIV-cases, (Data source: Estonian Health Board)
UNGASS narrative report, Estonia INTRODUCTION Estonia is the smallest of the three Baltic countries with a population of approximately 1.37 million people and the percentage of non-ethnic Estonians of
More informationHIV/AIDS, STI, hepatitis
ECDC update HIV/AIDS, STI, hepatitis HIV EU Think Tank meeting Brussels, 25-26 March 2009 European Centre for Disease Prevention and Control HIV and AIDS surveillance activities Coordination of European-wide
More informationAccess to needle and syringe exchange services in Estonia
Access to needle and syringe exchange services in Estonia presented by Aljona Kurbatova prepared by Aire Trummal (initially prepared for the workshop How do we know what works? (BZgA, WHO), Berlin, 23.10.2008)
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationThe Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC
The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections
More informationHIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
More informationGlobal health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
More informationGLOBAL AIDS MONITORING REPORT
KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017
More informationIntegration of collaborative TB/HIV activities with harm reduction services
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases control, Head of Department on HIV/AIDS combating
More information26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1
The 16 th Core Group Meeting of the TB/HIV Working Group 26 28 May 2010, Almaty, Kazkhstan Nina Kerimi UNODC Regional Project Coordinator 1 UNODC Regional Office for Central Asia covers 6 countries: AZE,
More informationHarm Reduction in Nigeria
Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous
More informationTechnical Guidance Note for Global Fund HIV Proposals
Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United
More informationNote: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.
Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting
More informationHIV, HBV and HCV testing policy experiences and lessons learned.
HIV, HBV and HCV testing policy experiences and lessons learned. Contents HIV and viral hepatitis: distinct epidemics at different stages of evolution Epidemiology: transmission, prevalence, incidence
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationHIV AND PEOPLE WHO INJECT DRUGS
UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
More informationPrevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies
Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don
More informationIntegrated harm reduction services for drug users and homeless people. Katrin Schiffer
Integrated harm reduction services for drug users and homeless people Katrin Schiffer Content Introduction Presentation of Correlation Network Harm Reduction in a nutshell basic principles and critical
More informationHIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres
HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS
More informationEMCDDA-update HIV/HCV among people who inject drugs: situation and response
EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis
More informationUNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
More informationAction plan for the health sector response to HIV in the WHO European Region DRAFT. istock//brauns
Action plan for the health sector response to HIV in the WHO European Region DRAFT istock//brauns Action plan for the health sector response to HIV in the WHO European Region DRAFT 5.4 This document remains
More informationHIV, Hepatitis and TB in Sweden Epidemiological data and prevention activities
HIV, Hepatitis and TB in Sweden Epidemiological data and prevention activities Maria Axelsson Public Health Agency of Sweden Number of cases HIV reported cases in Sweden 1983-2016 1000 900 800 700 600
More informationThe role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
More information3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019
3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 Cristiana Oprea MD, Ph.D Associate Professor Carol Davila University of Medicine and Pharmacy Victor Babes Clinical Hospital for Infectious
More informationReview on HIV & Associated Infections in Latvia
Review on HIV & Associated Infections in Latvia Dr.Inga Upmace, Infectology Center of Latvia Second meeting on EG on HIV/AIDS and AI April 7, 2011, Riga Negative influences: Several reorganizations of
More informationOF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan
Ratified President of the Republic of Armenia R. Kocharyan 1 April 2002 GOVERNMENT OF THE REPUBLIC OF ARMENIA DECREE 316 of 1 April 2002 Yerevan On ratification of the National Programme on HIV/AIDS Prevention
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationWHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections
Common structure Universal Health Coverage SDGs Cascade of services Vision, Goals and Targets Costed Actions WHO Global Health Sector Strategies 2016-2021 HIV; Viral Hepatitis; Sexually Transmitted Infections
More informationHarm reduction among drug users in Spain
Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández
More informationINTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
More information26 th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland June 2010
3 June 2010 26 th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland 22-24 June 2010 Next Programme Coordinating Board meetings Document prepared by the Programme Coordinating Board
More informationHIV testing in Europe: From policy to effectiveness
HIV testing in Europe: From policy to effectiveness 10 th Think Tank meeting Brussels, 9-10 April 2008 Françoise Hamers Scientific Advice Unit, ECDC ecdc.europa.eu Background About 30% of people living
More informationImplementing a priority national health care project in Russian Federation (HIV prevention and treatment)
Implementing a priority national health care project in Russian Federation (HIV prevention and treatment) Т.Т.Smolskaya 4-5 October 2006 Expert Group on HIV/AIDS for the NDPHS HIV in Russian Federation
More informationBUDGET AND RESOURCE ALLOCATION MATRIX
Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes
More informationMISSION REPORT. Country mission Estonia: HIV, sexually transmitted infections and hepatitis B and C October
MISSION REPORT Country mission Estonia: HIV, sexually transmitted infections and hepatitis B and C 11 13 October 2010 www.ecdc.europa.eu ECDC MISSION REPORT Country mission Estonia: HIV, sexually transmitted
More informationSUMMARY OF INTERIM REPORT
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit SUMMARY OF INTERIM REPORT Title: Empowering Civil Society and Public Health System to
More informationKey issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
More informationFIGHTING HIV IN ESTONIA IN 2006 AND Aire Trummal, Liilia Lõhmus, Kristi Rüütel
FIGHTING HIV IN ESTONIA IN 2006 AND 2007 Aire Trummal, Liilia Lõhmus, Kristi Rüütel Tallinn 2008 TABLE OF CONTENTS INTRODUCTION... 3 1. TRENDS OF HIV TRANSMISSION IN ESTONIA... 4 2. STRUCTURES FOR IMPLEMENTING
More informationEuropean HIV-Hepatitis Testing Week
European HIV-Hepatitis Testing Week COBATEST Network meeting Barcelona, Spain 14 May 2018 Lauren Combs, CHIP, Rigshospitalet, University of Copenhagen Background The first Testing Week was launched by
More informationAction plan for the health sector response to viral hepatitis in the WHO European Region
Action plan for the health sector response to viral hepatitis in the WHO European Region Dr Antons Mozalevskis WHO Regional Office for Europe VHPB Albania Country Meeting: Tirana, 27-28 October 2016 Chronic
More informationCity Profiles Recommendations on HIV prevention gaps and opportunities for Health Promotion among Men who have Sex with Men
Recommendations on HIV prevention gaps and opportunities for Health Promotion among Men who have Sex with Men This document is based on data from the Sialon II project, funded under the European Commission
More informationLinkages between Sexual and Reproductive Health and HIV
Linkages between Sexual and Reproductive Health and HIV Manjula Lusti-Narasimhan Department of Reproductive Health and Research World Health Organization The HIV pandemic 25 years 1981 2006 Rationale for
More informationImplementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.
SPECIAL REPORT Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report Summary www.ecdc.europa.eu ECDC SPECIAL REPORT Implementing the Dublin
More informationIntegrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China
Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China China presentation Wang Linhong MD, Professor National Center of MCH, China CDC 1 HIV/AIDS
More informationTOWARDS UNIVERSAL ACCESS
At a glance TOWARDS UNIVERSAL ACCESS Scaling up priority HIV/AIDS interventions in the health sector June 2008 Progress Report This document represents material excerpted from Towards universal access:
More informationELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD
ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD 17 May 2018 Bucharest, Romania Organisers Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe
More informationHIV in Prison Situation in Frankfurt am Main
HIV in Prison Situation in Frankfurt am Main European Project ROME-SEMINAR, May 14.-15., 2008 Horst Herkommer, Sella Oneko Praxis Psychosoziale Beratung Frankfurt am Main Germany General remark: Situation
More informationGOVERNMENT OF SIERRA LEONE NATIONAL HIV/AIDS POLICY
National HIV/AIDS Policy GOVERNMENT OF SIERRA LEONE NATIONAL HIV/AIDS POLICY NATIONAL HIV/AIDS POLICY FOR SIERRA LEONE 1. ACRONYMS CBOs - Community Based Organisations CAC/DAC/RAC - Chiefdom AIDS Committee/District
More informationVHPB MEETING ANTWERP 2014 ACHIEVEMENTS AND CHALLENGES IN PREVENTION AND CONTROL OF VIRAL HEPATITIS
POST-IT @ VHPB MEETING ANTWERP 2014 ACHIEVEMENTS AND CHALLENGES IN PREVENTION AND CONTROL OF VIRAL HEPATITIS East challenges Risk group vaccination problems Problems of anti-vaccine lobby Importance of
More informationThe impact of economic recession on drug users and drug treatment
The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry
More informationUnderstanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys
Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys Wim Vanden Berghe ITM HIV/AIDS center Department of Public Health Institute of
More informationContextual overview with reference to MDG Goal 6 and projection for Post-2015
Contextual overview with reference to MDG Goal 6 and projection for Post-2015 10th Partnership Annual Conference Side Event Combating HIV and TB through a joint regional action Helsinki, Finland November
More informationMay 26-28, 2010, Almaty, Kazakhstan November 2011
Progress note of the recommendations of the 16 th TB/HIV Core Group Meeting Report May 26-28, 2010, Almaty, Kazakhstan November 2011 1. Structural and organizational barriers The Core Group urges Ministries
More informationHighlight underserved groups for screening, prevention and treatment of viral hepatitis B and C in Europe LJUBLJANA, SLOVENIA March 2016
Viral Hepatitis Prevention Board Highlight underserved groups for screening, prevention and treatment of viral hepatitis B and C in Europe LJUBLJANA, SLOVENIA 10-11 March 2016 Objectives To define and
More informationEconomic and Social Council
United Nations Economic and Social Council Distr.: General 18 November 2014 Original: English Economic and Social Commission for Asia and the Pacific Asia-Pacific Intergovernmental Meeting on HIV and AIDS
More informationViral Hepatitis. WHO Regional Office for Europe July 2013
Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,
More informationUNGASS COUNTRY PROGRESS REPORT LATVIA
UNGASS COUNTRY PROGRESS REPORT LATVIA Reporting period: January 2008 December 2009 Submission date: March 31, 2010 TABLE OF CONTENTS TABLE OF CONTENTS 1 I. ABBREVIATIONS 2 II. STATUS AT GLANCE 4 III. OWERVIEW
More informationHIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for
More informationMaltese Presidency of the Council of the European Union. Ministry for Health
Maltese Presidency of the Council of the European Union Ministry for Health The Trio programme Guided by the strategic agenda of the European Council adopted in June 2014 One of the common priority areas
More informationHIV/AIDS Joint Action HA-REACT
HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission
More informationWHO Strategy and Goals for Viral Hepatitis Elimination
WHO Strategy and Goals for Viral Hepatitis Elimination No Disclosures Outline 1. Global strategy for elimination WHO targets and rationale 2. The global response so far Gaps in achieving the HBV and HCV
More informationNational HIV/STI Programme Overview
National HIV/STI Programme Overview HIV/AIDS IN JAMAICA Sero-prevalence among adults 1.7% Estimated No. with HIV/AIDS 27,000 (?31,000) Est. No. unaware of HIV status 15,000 No. of persons in need of ARV
More informationFAST-TRACK COMMITMENTS TO END AIDS BY 2030
FAST-TRACK COMMITMENTS TO END AIDS BY 2030 FAST-TRACK COMMITMENTS TO END AIDS BY 2030 90-90-90 1 Ensure that 30 million people living with HIV have access to treatment through meeting the 90 90 90 targets
More informationSTATE STRATEGY to Combat the Spread of HIV in Russia through 2020 and beyond
UNOFFICIAL TRANSLATION APPROVED by the Federal Government on October 20, 2016 STATE STRATEGY to Combat the Spread of HIV in Russia through 2020 and beyond I. General provisions State Strategy to Combat
More informationStockholm, April European Centre for Disease Prevention and Control, 2012 Reproduction is authorised, provided the source is acknowledged.
SPECIAL REPORT Monitoring implementation of the European Commission Communication and Action Plan for combating HIV/AIDS in the European Union and neighbouring countries, 2009 2013 www.ecdc.europa.eu ECDC
More informationAnnex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,
More informationPrevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008
Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe Lucca, Italy 13-14 March 2008 Objectives Review activities, role, rationale and impact
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationFeedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014
Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Dr. Nicole Werner-Keišs Lisbon, 16.10.2014 Outline Background, scope and objectives
More informationThe current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution
More informationKRAJOWE CENTRUM ds. AIDS DRAFT REPORT ON IMPLEMENTATION OF UNGASS DECLARATION OF COMMITMENT ON HIV/AIDS IN POLAND
KRAJOWE CENTRUM ds. AIDS DRAFT REPORT ON IMPLEMENTATION OF UNGASS DECLARATION OF COMMITMENT ON HIV/AIDS IN POLAND WARSAW, MARCH 31, 2010 2 TABLE OF CONTENTS I. INTRUCTION II. III. IV. LEADERSHIP AT THE
More informationImproving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative
Improving NSP and Harm Reduction Services Jason Farrell, European HCV and Drug Use Initiative Presentation Overview With the growing need to treat HCV, NSP programs have been identified in numerous stakeholder
More informationWorld Health Organization HIV/TB Facts 2011
World Health Organization HIV/TB Facts 20 Note: The facts and figures of the HIV/TB Facts 20 are drawn from WHO HIV and TB surveillance data from 200 and 2009, as referenced below. Why is tuberculosis
More informationPublic health dimension of the world drug problem
SEVENTIETH WORLD HEALTH ASSEMBLY A70/29 Provisional agenda item 15.3 27 March 2017 Public health dimension of the world drug problem Report by the Secretariat 1. The Executive Board at its 140th session
More informationPrevention and control of hepatitis B and C in the European Region of WHO
Prevention and control of hepatitis B and C in the European Region of WHO Viral Hepatitis Prevention Board Dr Nedret Emiroglu WHO Regional Office for Europe Burden of viral hepatitis in the European Region
More informationCivil Society Driven Response in Ukraine: A program making a difference and bringing results
Civil Society Driven Response in Ukraine: A program making a difference and bringing results CATIE Forum Making it work: From Planning to Practice October 16th, 2015 Andriy Klepikov International HIV/AIDS
More informationThe EACS Standard of Care initiative. The Standard of Care for HIV and Coinfections in Europe meeting in Rome: a reminder
The EACS Standard of Care initiative. The Standard of Care for HIV and Coinfections in Europe meeting in Rome: a reminder Antonella d Arminio Monforte, University of Milan Cristina Mussini, University
More information